A concern that drug companies cannot ignore.
作者信息
Wager Elizabeth
机构信息
Sideview, Station Road, Princes Risborough HP27 9DE, UK.
出版信息
J R Soc Med. 2005 Oct;98(10):448-50. doi: 10.1177/014107680509801008.
Abstract
摘要
相似文献
1
A concern that drug companies cannot ignore.制药公司不能忽视的一个问题。
J R Soc Med. 2005 Oct;98(10):448-50. doi: 10.1177/014107680509801008.
2
Sponsorship, authorship and accountability.赞助、作者身份与责任。
N Z Med J. 2001 Dec 14;114(1145):558; author reply 559.
3
Sponsorship, authorship and accountability.赞助、作者身份与责任。
N Z Med J. 2001 Dec 14;114(1145):558; author reply 559.
4
Sponsorship, authorship and accountability.赞助、作者身份与责任。
N Z Med J. 2001 Dec 14;114(1145):558; author reply 559.
5
Sponsorship, authorship and accountability.赞助、作者身份与责任。
N Z Med J. 2001 Dec 14;114(1145):558-9.
6
Authorship policy.作者政策。
Am J Ophthalmol. 2009 Jan;147(1):184; author reply 184-5. doi: 10.1016/j.ajo.2008.09.031.
7
[Scientific reporting guidelines].[科学报告指南]
Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2340. doi: 10.4045/tidsskr.09.1099.
8
How to ensure our readers' trust: the proper attribution of authors and contributors.如何确保读者的信任：作者和贡献者的恰当署名
Am J Ophthalmol. 2008 Sep;146(3):337-40. doi: 10.1016/j.ajo.2008.06.007.
9
[Knowledge on feet of clay].[徒有其表的知识]
Lakartidningen. 2008;105(19):1405-6.
10
The end of scientific articles as we know them?我们所熟知的科学论文的终结？
J Clin Epidemiol. 2016 Feb;70:276. doi: 10.1016/j.jclinepi.2015.06.017. Epub 2015 Jul 8.
本文引用的文献
1
Ghost writing initiated by commercial companies.由商业公司发起的代笔行为。
J Gen Intern Med. 2005 Jun;20(6):549. doi: 10.1111/j.1525-1497.2005.41015.x.
2
Next steps in trial registration.试验注册的后续步骤。
BMJ. 2005 May 28;330(7502):1222-3. doi: 10.1136/bmj.330.7502.1222.
3
Medical editors issue guidance on ghost writing.医学编辑发布了关于代笔的指导意见。
BMJ. 2005 Apr 30;330(7498):988. doi: 10.1136/bmj.330.7498.988-a.
4
A uniform clinical trial registration policy for journals of kidney diseases, dialysis, and transplantation.
Transplantation. 2005 Apr 15;79(7):751. doi: 10.1097/00007890-200504150-00001.
5
European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications.欧洲医学撰写人协会（EMWA）关于医学撰写人在同行评审出版物撰写中所起作用的指南。
Curr Med Res Opin. 2005 Feb;21(2):317-22. doi: 10.1185/030079905X25578.
6
Clinical trial registration: a statement from the International Committee of Medical Journal Editors.临床试验注册：国际医学期刊编辑委员会声明
Lancet. 2004;364(9438):911-2. doi: 10.1016/S0140-6736(04)17034-7.
7
Pfizer pleads guilty, but drug sales continue to soar.辉瑞认罪，但药品销售额仍在飙升。
BMJ. 2004 May 22;328(7450):1217. doi: 10.1136/bmj.328.7450.1217.
8
Good publication practice for pharmaceutical companies.制药公司良好出版规范。
Curr Med Res Opin. 2003;19(3):149-54. doi: 10.1185/030079903125001767.
9
Lessons for research ethics committees.
Lancet. 2002 Jan 12;359(9301):174. doi: 10.1016/s0140-6736(02)07361-0.
10
A ghostly crew.一群幽灵般的人。
Lancet. 1998 Apr 11;351(9109):1076. doi: 10.1016/S0140-6736(05)79376-4.
Zotero 插件